Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INSM
#553
Insmed Incorporated - Common Stock
98.5
6
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.03%
Monthly Change
-23.89%
6 month change
-35.25%
Year Change
-39.18%
Previous Close
100.6
0
Open
98.8
2
Low
98.3
3
High
100.3
1
Markets
US Stock Market
Healthcare
Biotechnology
INSM
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
103.04 M
118.9 M
136.41 M
148.49 M
181 M
215.55 M
218.38 M
Valuation ratios
Enterprise value
3.25 B
3.09 B
2.67 B
5.12 B
13.05 B
37.55 B
21.24 B
Price to earnings ratio
-11.05
-7.02
-4.91
-5.61
-12.39
-27.11
-23.61
Price to sales ratio
19.76
16.2
9.62
13.78
31.14
57.12
18.09
Price to cash flow ratio
-14.81
-8.41
5.89
7.84
16.56
-37.04
-26.12
Price to book ratio
11.78
7.44
26.83
12.67
39.69
46.87
6.51
Enterprise value to EBITDA ratio
-12.71
-8.44
-5.9
-7.27
-15.21
-30.74
-26.27
Profitability ratios
Return on assets %
-0.37
-0.35
-0.29
-0.56
-0.45
-0.56
-0.01
Return on equity %
-1.07
-1.06
-5.48
2.26
-3.2
-1.73
-0.02
Return on invested capital %
-490.87
-455.18
-436.18
-704.91
-845.81
-1 036.25
-1.42
Gross margin %
75.75
76.57
77.53
78.52
76.43
79.73
84.2
Operating margin %
-161.32
-199.03
-186.39
-232.51
-241.47
-205.59
-0.36
EBITDA margin %
-155.79
-194.2
-184.23
-230.7
-235.81
-201.41
1.37
Net margin %
-178.87
-230.63
-196.26
-245.59
-251.24
-210.54
-3.11
Liquidity ratios
Quick ratio
4.83
5.7
6.33
3.75
5.12
3.54
3.4
Current ratio
5.24
6.19
6.69
4.12
5.45
3.83
3.72
Inventory turnover
1.02
0.76
0.81
0.86
0.94
0.93
0.49
Asset turnover
0.21
0.18
0.17
0.2
0.22
0.27
0.2
Solvency ratios
Debt to assets ratio
0.45
0.46
0.68
0.87
0.54
0.24
0.26
Debt to equity ratio
1.29
1.38
12.79
-3.48
3.87
0.73
0.72
Long term debt to total assets ratio
0.57
0.64
0.7
0.89
0.55
0.24
0.26
Long term debt to total equity ratio
1.63
1.95
13.12
-3.55
3.93
0.74
0.72
Per share metrics
Operating cash flow per share
-2.25
-3.24
-3.25
-3.82
-4.17
-4.7
-3.72
EBIT per share
-2.72
-3.35
-3.72
-5.05
-5.35
-6.26
-4.05
EBITDA per share
-2.62
-3.26
-3.67
-5.01
-5.23
-6.14
-3.9
Total debt per share
3.65
5.05
9.15
8.23
6.73
2.72
2.52
Cash per share
5.46
6.39
9.33
5.56
8.74
7.19
5.34
Net current asset value per share
6.38
7.47
10.35
6.62
9.89
9.02
7.52
Tangible book value per share
2.83
3.66
0.71
-2.36
1.74
2.54
2.43
Working capital per share
5.16
6.26
8.8
5.01
8.07
6.66
5.5
Book value per share
2.83
3.66
0.71
-2.36
1.74
3.71
3.49
News
This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Wolfe Research Downgrades Insmed to Peer Perform
HC Wainwright & Co. Reiterates Buy on Insmed, Announces $220 Price Target
INSM Stock Slides on CFO Exit, Reiterates '26 Sales View
$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today
Stocks Settle Higher as Big Tech Rallies
Nasdaq 100 Hits Record, Brazil's EWZ Soars 13%: Stock Market Today
Insmed Stock Slides — CFO Exit Date Set, 2026 Guidance Reaffirmed
Stocks Mostly Higher as Crude Prices Fall
Stocks Supported by M&A Activity and Lower Crude Oil Prices
Insmed Q2 2026 Earnings Call Transcript
Insmed Reaffirms FY26 Revenue Guidance Of $1.25B-$1.40B For BRINSUPRI And $450M- $470M For ARIKAYCE